Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 15 min 33 sec ago

Integra LifeSciences Launches Integra(R) Reinforcement Matrix

Wed, 01/21/2015 - 18:21
Designed for Use During Tendon Healing PLAINSBORO, N.J., Jan. 21, 2015 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced the full market release of Integra(R) Reinforcement Matrix, a biological...
Devices, Orthopaedic, Product Launch
Integra LifeSciences, Reinforcement Matrix, Stellen Medical

Cohera Medical, Inc.(R) Enters Agreement with B. Braun Surgical, S.A. for Distribution of TissuGlu(R) Surgical Adhesive in Select European Countries

Wed, 01/21/2015 - 18:11
PITTSBURGH, Jan. 21, 2015 -- (Healthcare Sales & Marketing Network) -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has entered into an exclusive sales and marketing di...
Devices, Surgery, Distribution
Cohera Medical, B. Braun, TissuGlu, Surgical Adhesive

Medivir Makes Change within the Management Team

Wed, 01/21/2015 - 16:41
STOCKHOLM--(Healthcare Sales & Marketing Network)--Medivir AB (OMX:MVIR) (STO:MVIRB) announces a reorganization of the management team in order to streamline and increase operational focus. After the change the company´s management team consists of 6...
Biopharmaceuticals, Personnel
Medivir AB

NovaBay Expands Sales Force for Avenova

Tue, 01/20/2015 - 13:27
35-person sales team to market NovaBay’s breakthrough Avenova product to ophthalmologists and optometrists in every major U.S. market NovaBay management and key industry opinion leaders to hold an investment community conference call tomorrow, January ...
Biopharmaceuticals, Ophthalmology
NovaBay Pharmaceuticals, Avenova, blepharitis

Akers Expands U.S. Sales Efforts With Key Leadership Additions

Tue, 01/20/2015 - 13:21
THOROFARE, N.J., Jan. 20, 2015 -- (Healthcare Sales & Marketing Network) -- Akers Biosciences, Inc. (AKER) (AIM:AKR.L), (the "Company"), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the recruit...
Diagnostics, Personnel
Akers Biosciences

Gecko Biomedical Receives 1.3 Million Euros From Bpifrance to Advance its Bio-Inspired Surgical Adhesive Solutions

Tue, 01/20/2015 - 13:14
PARIS, January 20, 2015 -- (Healthcare Sales & Marketing Network) -- Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, announces today it has received 1.3 million euros ...
Devices, Surgery, Venture Capital
Gecko Biomedical, surgical adhesive, surgical glue

CytRx Announces FDA's Removal of Partial Clinical Hold for Aldoxorubicin Clinical Trials Permitting Immediate Enrollment of New Patients

Tue, 01/20/2015 - 13:07
Company does not expect estimated timelines to materially change LOS ANGELES, Jan. 20, 2015 -- (Healthcare Sales & Marketing Network) -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today anno...
Biopharmaceuticals, Oncology, FDA
CytRx, aldoxorubicin

ECA Medical Instruments Develops First Disposable Spinal Instrument Fixation Kit to Gain FDA Approval with Intelligent Implant Systems

Fri, 01/16/2015 - 13:21
Intelligent Implant Systems Revolution Spinal System™ features ECA’s sterile packed, disposable instrument set to ease workflow, save cost and boost OR efficiency in inpatient and outpatient settings. THOUSAND OAKS, Calif.--(Healthcare Sales & Marketing...
Devices, Orthopaedic, Neurosurgery, FDA
ECA Medical Instruments, Revolution Spinal System, spine surgery

European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) for the Treatment of Chronic Hepatitis C

Fri, 01/16/2015 - 13:09
In Phase 3 clinical trials, VIEKIRAX + EXVIERA cured 95-100 percent of genotype 1 chronic hepatitis C patients, with less than 2 percent of patients experiencing virologic failure[1],[2] Tolerability profile shows more than 98 percent of patients comple...
Biopharmaceuticals, Regulatory
AbbVie , VIEKIRAX, EXVIERA, hepatitis C

OCuSOFT(R) Introduces HypoChlor(TM) Spray and Gel (Hypochlorous Acid 0.02%) As Adjunct Therapy to its Lid Scrub(R) Family of Eyelid Cleansers

Thu, 01/15/2015 - 20:08
RICHMOND, Texas--(Healthcare Sales & Marketing Network)--OCuSOFT Inc., an ophthalmic pharmaceutical company (the “Company”) with an established reputation for innovation in eyelid hygiene and ocular health, is pleased to announce the availability of OCuSOF...
Biopharmaceuticals, Ophthalmology, Product Launch
OCuSOFT, Lid Scrub, Hypochlorous acid

Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer

Thu, 01/15/2015 - 16:12
CAMBRIDGE, Mass., Jan.15, 2015 -- (Healthcare Sales & Marketing Network) -- Seres Health, Inc., a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat diseases by restoring the function o...
Biopharmaceuticals, Personnel
Seres Health, dysbiotic, microbiome

Amniox Medical Appoints Thomas J. Dugan as Chief Executive Officer

Wed, 01/14/2015 - 13:48
Established Healthcare Executive Brings Significant Experience in Medical Devices and Wound Care to Amniox ATLANTA & MIAMI--(Healthcare Sales & Marketing Network)--Amniox Medical, Inc. ("Amniox", the "Company"), a leading provider of...
Regenerative Medicine, Wound Care, Personnel
Amniox Medical, CRYOTEK, AmnioGraft

NeuroPhage Expands Series D Financing To $27 Million

Wed, 01/14/2015 - 13:41
Funds Will Advance Breakthrough Drug Candidate NPT088 into the Clinic CAMBRIDGE, Mass., Jan. 14, 2015 -- (Healthcare Sales & Marketing Network) -- NeuroPhage Pharmaceuticals, Inc., today announced that it has closed $10.0 million from new investors in ...
Biopharmaceuticals, Neurology, Venture Capital
NeuroPhage Pharmaceuticals, NPT088, neurodegenerative

Tissue Regeneration Systems Adds Business Development Executive

Wed, 01/14/2015 - 13:35
PLYMOUTH, Mich., Jan. 14, 2015 -- (Healthcare Sales & Marketing Network) -- Tissue Regeneration Systems, Inc. ("TRS") today announced that Sharon Schulzki has joined the company as Senior Vice President of Business Development. Prior to joining...
Devices, Personnel
Tissue Regeneration Systems

Teleflex Incorporated Highlights Article on ARROW(R) VPS(R) Vascular Positioning System, Showing Significant Reduction in Catheter Malpositions

Tue, 01/13/2015 - 13:15
Article Shows Advantages of Using System that Replaces Chest X-Ray to Check Central IV Line Placement WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and sur...
Devices
Teleflex, ARROW VPS, ARROW, Vascular Positioning System

Teleflex Reports Study Results of ARROWg+ard(R) Technology Effectiveness in Preventing Infections and Associated Costs in an Infection-Prone Insertion Site

Tue, 01/13/2015 - 13:09
Peer-Reviewed Published Research Reconfirms Clinical Benefits and Cost-Effectiveness of Chlorhexidine/Silver Sulfadiazine-Impregnated CVC WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medic...
Devices
Teleflex, ARROWg+ard, ARROW

Teleflex Awarded HealthTrust Agreement for Peripherally Inserted Central Catheter (PICC) Products

Tue, 01/13/2015 - 13:02
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with HealthTrust covering PICC (peripherally inserted central cathete...
Devices, Group Purchasing
Teleflex, HealthTrust, ARROW, PICC

ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer

Tue, 01/13/2015 - 12:58
EDISON, N.J., Jan. 13, 2015 -- (Healthcare Sales & Marketing Network) -- ContraVir Pharmaceuticals, Inc. (CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today the appointment ...
Biopharmaceuticals, Personnel
ContraVir Pharmaceuticals

MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO

Mon, 01/12/2015 - 16:59
Alfred Mann to Remain Focused on Development and Financing of Future Products of MannKind VALENCIA, Calif., Jan. 12, 2015 -- (Healthcare Sales & Marketing Network) -- MannKind Corporation (MNKD), a biopharmaceutical-based technology company, today annou...
Biopharmaceuticals, Personnel
MannKind

Debiopharm Group(TM) Regains Full Rights to Alisporivir Program

Mon, 01/12/2015 - 12:44
Novartis returns Alisporivir (DEB025) to Debiopharm Group™ including all rights for HCV and other indications LAUSANNE, Switzerland, January 12, 2015 -- (Healthcare Sales & Marketing Network) -- Debiopharm Group™ (Debiopharm), a Swiss-based global biop...
Biopharmaceuticals
Debiopharm Group, Novartis, Alisporivir, Hepatitis C

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong